Abstract

BackgroundHuman immunodeficiency virus (HIV) pre-exposure prophylaxis (PrEP) is highly effective in preventing HIV transmission, yet patients interested in learning more about PrEP or in getting a PrEP prescription may not be able to find local medical providers willing to prescribe PrEP.ObjectiveWe sought to create a national database of PrEP-providing clinics to allow for patients to have access to a unified, vetted source of PrEP providers in an easily accessible database.MethodsTo develop the protocol and operating procedures for the PrEP Locator, we conducted a series of 7 key informant interviews with experts who had organized PrEP or other HIV service directories. We convened an external advisory committee and a collaborators board to gain expert and community-situated perspectives.ResultsAt its public release in September 2016, the database included 1,272 PrEP-providing clinics, including clinics in all 50 states and in Puerto Rico. Web searches, referrals, and outreach to state health departments identified 58 unique lists of PrEP-providing clinics, with 33 from state health departments, 6 from government localities, 2 from professional medical organizations, and 19 from nongovernmental organizations. Out of the 2,420 clinics identified from the lists and Web searches, we removed 798 as duplicate entries, and we determined that 350 were ineligible for listing. The most common reasons for ineligibility were not having the appropriate medical licensure to prescribe PrEP (67/350) or not prescribing PrEP, based on self-report (192/350). Key informant interviews shaped important protocol decisions, such as listing clinics instead of individual clinicians as the primary data element and streamlining data collection to facilitate scalability. We developed a Web interface to provide public access to the data, with geolocated data display, search filter functionality, a webform for public suggestions of new clinics, and a publicly available directory Web tool that can be embedded in websites. In the 6 months following release, preplocator.org and hosting websites had received over 35,000 unique views and 300 clinic additions, and 5 websites had initiated hosting of the widget.ConclusionsDirectories exist for many preventive and treatment services. As new medical applications become available, there will be a corresponding need to develop new directories for service provision. Geolocated directories can assist patients in accessing care and have the potential to increase demand for and access to newer, more efficacious medical interventions. Early choices in the development of service directories have long-lasting impact, because once data collection begins, it can be challenging to reverse course. The PrEP Locator protocol may inform early decisions in the development of future service directories. Additionally, the case study on developing the PrEP Locator demonstrates the importance of formative work in identifying service-specific factors that can guide decisions on directory development.

Highlights

  • Human immunodeficiency virus (HIV) pre-exposure prophylaxis (PrEP) is highly efficacious in preventing HIV, preventing between 56% and 100% of new infections across several effectiveness studies [1,2,3]

  • Bringing PrEP to scale would have a substantial impact on the overall HIV epidemic, with one mathematical model indicating that scaling PrEP use to 40% of eligible men who have sex with men (MSM) based on US Centers for Disease Control and Prevention (CDC) eligibility criteria would reduce the number of new HIV infections in this group by 33% [4]

  • We developed an accessible tool for patients to search for clinics in a geolocated fashion, hosted at preplocator.org

Read more

Summary

Introduction

HIV pre-exposure prophylaxis (PrEP) is highly efficacious in preventing HIV, preventing between 56% and 100% of new infections across several effectiveness studies [1,2,3]. Bringing PrEP to scale would have a substantial impact on the overall HIV epidemic, with one mathematical model indicating that scaling PrEP use to 40% of eligible men who have sex with men (MSM) based on US Centers for Disease Control and Prevention (CDC) eligibility criteria would reduce the number of new HIV infections in this group by 33% [4]. This intervention is cost-effective for at-risk MSM [5,6,7]. Human immunodeficiency virus (HIV) pre-exposure prophylaxis (PrEP) is highly effective in preventing HIV transmission, yet patients interested in learning more about PrEP or in getting a PrEP prescription may not be able to find local medical providers willing to prescribe PrEP

Methods
Results
Discussion
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.